Literature DB >> 17267119

The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder.

Peter B Hedlund1, J Gregor Sutcliffe.   

Abstract

The 5-HT7 receptor has been suggested as a new putative target for the treatment of neuropsychiatric disorders, especially depression. This hypothesis is based on the finding that antidepressant drugs have relatively high affinity for the 5-HT7 receptor, and that inactivation or blockade of the receptor leads to an antidepressant-like profile in behavioral models and sleep parameters. Obsessive-compulsive disorder is also believed to involve the serotonergic system and is treated using antidepressants, thus it is of interest to study the possible role of the 5-HT7 receptor in this disorder. We have evaluated the effect of inactivation or pharmacological blockade of the 5-HT7 receptor in three mouse behavioral models that are believed to mimic some of the stereotypic aspects of obsessive-compulsive disorder. In the most well-established behavioral model, marble burying, both inactivation and blockade of the 5-HT7 receptor reduced stereotypic behavior in that the number of marbles buried decreased. In two newer, less well-characterized models, head dipping and plastic-mesh screen chewing, there was no difference between wild-type mice and mice lacking the 5-HT7 receptor. Taken together the data confirms and expands on previous findings that the 5-HT7 receptor is of importance for behaviors affected by antidepressants, and suggests that the 5-HT7 receptor might be of relevance as a target for the treatment of obsessive-compulsive disorder.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17267119      PMCID: PMC1849956          DOI: 10.1016/j.neulet.2006.12.054

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  37 in total

1.  GABAergic modulation of 5-HT7 receptor-mediated effects on 5-HT efflux in the guinea-pig dorsal raphe nucleus.

Authors:  Claire Roberts; David R Thomas; Simon T Bate; James N C Kew
Journal:  Neuropharmacology       Date:  2004-06       Impact factor: 5.250

2.  Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.

Authors:  Anna Wesołowska; Agnieszka Nikiforuk; Katarzyna Stachowicz; Ewa Tatarczyńska
Journal:  Neuropharmacology       Date:  2006-07-07       Impact factor: 5.250

Review 3.  Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.

Authors:  Schaun Korff; Brian H Harvey
Journal:  Psychiatr Clin North Am       Date:  2006-06

Review 4.  Obsessive-compulsive disorder.

Authors:  I Heyman; D Mataix-Cols; N A Fineberg
Journal:  BMJ       Date:  2006-08-26

Review 5.  Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.

Authors:  Bernardo Dell'Osso; Gerald Nestadt; Andrea Allen; Eric Hollander
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

6.  Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.

Authors:  Kazufumi Hirano; Ryohei Kimura; Yumi Sugimoto; Jun Yamada; Shinya Uchida; Yasuhiro Kato; Hisakuni Hashimoto; Shizuo Yamada
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

7.  Animal models with potential applications for screening compounds for the treatment of obsessive-compulsive disorder.

Authors:  A Woods-Kettelberger; S Kongsamut; C P Smith; J T Winslow; R Corbett
Journal:  Expert Opin Investig Drugs       Date:  1997-10       Impact factor: 6.206

8.  Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression.

Authors:  M Guscott; L J Bristow; K Hadingham; T W Rosahl; M S Beer; J A Stanton; F Bromidge; A P Owens; I Huscroft; J Myers; N M Rupniak; S Patel; P J Whiting; P H Hutson; K C Fone; S M Biello; J J Kulagowski; G McAllister
Journal:  Neuropharmacology       Date:  2005-03       Impact factor: 5.250

9.  Serotonin receptor 1A knockout: an animal model of anxiety-related disorder.

Authors:  S Ramboz; R Oosting; D A Amara; H F Kung; P Blier; M Mendelsohn; J J Mann; D Brunner; R Hen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

10.  5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice.

Authors:  Y Ichimaru; T Egawa; A Sawa
Journal:  Jpn J Pharmacol       Date:  1995-05
View more
  16 in total

Review 1.  Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders.

Authors:  Marcello Leopoldo; Enza Lacivita; Francesco Berardi; Roberto Perrone; Peter B Hedlund
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

Review 2.  Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectives.

Authors:  Anne Matthys; Guy Haegeman; Kathleen Van Craenenbroeck; Peter Vanhoenacker
Journal:  Mol Neurobiol       Date:  2011-03-22       Impact factor: 5.590

3.  The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamide.

Authors:  Surabi Veeraragavan; Nghiem Bui; Jennie R Perkins; Lisa A Yuva-Paylor; Richard Paylor
Journal:  Behav Neurosci       Date:  2011-10       Impact factor: 1.912

4.  l-theanine attenuates abstinence signs in morphine-dependent rhesus monkeys and elicits anxiolytic-like activity in mice.

Authors:  Laura E Wise; Ishani D Premaratne; Thomas F Gamage; Aron H Lichtman; Larry D Hughes; Louis S Harris; Mario D Aceto
Journal:  Pharmacol Biochem Behav       Date:  2012-08-23       Impact factor: 3.533

5.  Disruption to the 5-HT7 Receptor Following Hypoxia-Ischemia in the Immature Rodent Brain.

Authors:  Julie A Wixey; Hanna E Reinebrant; Kirat K Chand; Kathryn M Buller
Journal:  Neurochem Res       Date:  2018-01-22       Impact factor: 3.996

6.  Bi-directional modulation of bed nucleus of stria terminalis neurons by 5-HT: molecular expression and functional properties of excitatory 5-HT receptor subtypes.

Authors:  J-D Guo; S E Hammack; R Hazra; L Levita; D G Rainnie
Journal:  Neuroscience       Date:  2009-09-22       Impact factor: 3.590

7.  Pharmacological stimulation of the brain serotonin receptor 7 as a novel therapeutic approach for Rett syndrome.

Authors:  Bianca De Filippis; Paola Nativio; Alessia Fabbri; Laura Ricceri; Walter Adriani; Enza Lacivita; Marcello Leopoldo; Francesca Passarelli; Andrea Fuso; Giovanni Laviola
Journal:  Neuropsychopharmacology       Date:  2014-05-09       Impact factor: 7.853

Review 8.  The 5-HT7 receptor and disorders of the nervous system: an overview.

Authors:  Peter B Hedlund
Journal:  Psychopharmacology (Berl)       Date:  2009-08-01       Impact factor: 4.530

Review 9.  Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease.

Authors:  Andrew Holmes
Journal:  Neurosci Biobehav Rev       Date:  2008-03-26       Impact factor: 8.989

10.  A Synbiotic Mixture Augmented the Efficacy of Doxepin, Venlafaxine, and Fluvoxamine in a Mouse Model of Depression.

Authors:  Azadeh Mesripour; Andiya Meshkati; Valiollah Hajhashemi
Journal:  Turk J Pharm Sci       Date:  2020-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.